Oncologists urged to embrace biosimilars to help control spiralling costs of cancer care

Author(s): GaBI Journal Editor

Oncologists urged to embrace biosimilars to help control spiralling costs of cancer care Oncologists have been urged to embrace biosimilar drug substitution to help control the spiralling costs of cancer care. However, they have been warned that the optimal realisation of such a programme requires successful educational initiatives and the development of effective working partnerships with pharmacists and patients [1]. […]

Read more →